Latest News about PFE
Recent news which mentions PFE
3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street
October 01, 2023
From Motley Fool
Moderna's Shares Could Take Off if These 2 Things Happen
September 30, 2023
From Motley Fool
Why Pfizer and BioNTech Stocks Zoomed Higher Today
September 29, 2023
From Motley Fool
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
September 29, 2023
From Benzinga
Volatility, gold and stocks to avoid: Citi delivers its shutdown playbook
September 29, 2023
From MarketWatch
Smart Picks: 7 Blue-Chips Trading Below True Value
September 28, 2023
From InvestorPlace
Don’t Miss the Boom: 3 Pharma Stocks Set to Explode Higher
September 27, 2023
From InvestorPlace
Challenging Road Ahead for Cancer Drugs, Nuvalent Seeks to Break the Mold
September 27, 2023
From Benzinga
What's Going On Pfizer's Subsidiary Biohaven Stock?
September 27, 2023
From Benzinga
Why Ginkgo Bioworks Stock Is Surging Higher Today
September 27, 2023
From Motley Fool
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
September 27, 2023
From Benzinga
Mainz Biomed To Present The Power Of mRNA That Promises To Revolutionize Medicine
September 27, 2023
From Benzinga
These 2 Stocks Are Getting Smart Investors' Attention Wednesday
September 27, 2023
From Motley Fool
Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
September 27, 2023
From Benzinga
Pfizer Is Sending Ginkgo Bioworks (DNA) Stock Higher: Here's Why
September 27, 2023
From Benzinga
DNA Stock Alert: Ginkgo Bioworks Announces Major Partnership With Pfizer
September 27, 2023
From InvestorPlace
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
September 27, 2023
From Benzinga
Uncertainty Looms Over Pfizer's Oral COVID-19 Antiviral Pill - Doubts Over Commercial Approval
September 27, 2023
Tickers
PFE
From Benzinga
2 Magnificent Growth Stocks to Buy On the Dip
September 27, 2023
From Motley Fool
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
September 26, 2023
From Benzinga
Gundlach fears a recession. Here are his low-risk, income-generating investment picks.
September 26, 2023
From MarketWatch
Coty shares fall after announcing offering, and other movers early Tuesday
September 26, 2023
From MarketWatch
Pfizer restarts production at tornado-damaged facility, but some supply is still affected
September 25, 2023
From MarketWatch
From Benzinga
CDC Backs Pfizer's RSV Infection Maternal Vaccine During Pregnancy As Protection For Infants
September 25, 2023
From Benzinga
Beware! 3 Healthcare Stocks Waving Massive Red Flags Right Now.
September 24, 2023
From InvestorPlace
Pfizer maternal RSV vaccine recommended by CDC advisers
September 22, 2023
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.